MUCOS Pharma GmbH & Co. KG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 1949-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.wobenzym.de
Study to Investigate the Mechanism of Action of an Oral Enzyme Treatment With Bromelain, Trypsin and Rutoside Versus Placebo in Subjects With OsTeoarthritis
Not Applicable
Completed
- Conditions
- Osteoarthritis
- Interventions
- Other: PlaceboDrug: Wobenzym®
- First Posted Date
- 2021-09-09
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Mucos Pharma GmbH & Co. KG
- Target Recruit Count
- 40
- Registration Number
- NCT05038410
- Locations
- 🇧🇪
Ziekenhuis Netwerk Antwerpen (ZNA) Middelheim, Antwerpen, Belgium
🇧🇪Centre Hospitalier Universitaire (CHU) Brugmann, Bruxelles, Belgium
🇧🇪Cliniques Universitaires Saint Luc UCL, Bruxelles, Belgium
Phlogenzym® in Patients With Acute Thrombophlebitis - Efficacy and Tolerance
Phase 3
Completed
- Conditions
- Thrombophlebitis Leg
- Interventions
- Drug: PhlogenzymOther: Placebo
- First Posted Date
- 2018-03-19
- Last Posted Date
- 2018-03-19
- Lead Sponsor
- Mucos Pharma GmbH & Co. KG
- Target Recruit Count
- 100
- Registration Number
- NCT03470337
- Locations
- 🇮🇹
Dr. Baumueller, Fano, Italy
Effects of Wobenzym® Plus in Healthy, Sportive People After Eccentric Exercise
Phase 4
Completed
- Conditions
- Muscle InjuryMuscle SorenessExercise Induced Muscle Damage
- Interventions
- Drug: Wobenzym® plusOther: Placebo
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2015-08-28
- Lead Sponsor
- Mucos Pharma GmbH & Co. KG
- Target Recruit Count
- 69
- Registration Number
- NCT01845558
- Locations
- 🇩🇪
Sportschule FFb Puch GmbH, Fürstenfeld Bruck, Germany
© Copyright 2025. All Rights Reserved by MedPath